News & Events

 

Startups in the News

  • Clinipace Worldwide Co-Founder and CEO Jeff Williams to Resign (GlobeNewswire)
    Jeff Williams, co-founder, president, and CEO of Clinipace Worldwide, a global full-service clinical research organization (CRO) that he founded 14 years ago, has elected to move into an expanded advisory role with the company’s Board of Directors. He will be handing over his responsibilities to Jason Monteleone, who will assume the role of Chief Executive Officer.  Williams will remain a Director and will focus on strategic initiatives on behalf of the Board of Directors. Williams started the company in 2003 with the desire to leverage technology in new ways to improve the way clinical research is conducted.  Today, the company is one of the top 15 CROs in the industry and employs more than 800 employees worldwide.... Read more »
  • ViewRay: Early Data Suggests 2X Prolonged Median Survival for Inoperable Pancreatic Cancer Treated with MRIdian (StreetInsider)
    ViewRay, Inc., maker of the world’s first and only clinical MRI-guided radiation therapy system, announced outcomes data presented during the recent 2017 Annual Meeting of the American Society for Radiation Oncology (ASTRO). This data highlighted compelling early results using the company’s MRIdian system for the treatment of inoperable, locally advanced pancreatic cancer. Unlike any other system on the market today, MRIdian allows clinicians to see the tumor and nearby soft-tissue anatomy throughout radiation treatments using real-time diagnostic MR-visualization. As a result, MRIdian’s on-table adaptive radiation therapy allows doctors to respond to subtle anatomical changes observed on a day-to-day basis and reshape the dose to better match the current contours of the tumor. By more accurately targeting the tumor, and reducing treatment radiation dose to surrounding organs such as the duodenum, small bowel, stomach and liver, a higher and potentially more effective radiation dose may be delivered without increasing the risks of side effects and complications for the patient.... Read more »
  • Nanotherapeutics Is Now Ology Bioservices (BusinessWire)
    Nanotherapeutics, Inc. announced that the company has changed its name to Ology Bioservices, Inc., effective immediately. The name change is part of a broader rebranding effort and directly reflects the company’s evolution from a products and formulations company toward its goal of becoming one of the industry’s top contract development and manufacturing organizations (CDMO), with differentiated expertise in biologics and vaccines. With its broad service offering, Ology Bioservices is building a commercial client base consisting of leading companies focused on research and development of biologics and vaccines for both preventative and therapeutic use.... Read more »
  • Verigo Launches Extreme Temperature Data Logger (DC Velocity)
    UF startup Verigo has added a new device to its suite of products. Pod Probe enables customers to monitor extreme temperatures with the same cutting-edge technology and real-time data analysis offered in previous Verigo Pods. Pod Probe, measuring temperatures of -80°C to 80°C (-112° F to 176°F), records and wirelessly transmits temperature data and excursion alerts to the user’s smartphone or tablet. Probe’s 2-meter (6.5-foot) cable allows it to measure extreme temperatures past the capabilities of the Pod shell itself. This feature gives users the capability to measure temperatures outside the threshold of most industry data loggers. Verigo’s mobile app enables users to view Pod activity up to 30 meters (100 feet) away. This feature ensures the product is never neglected during transit.... Read more »
  • ViewRay Launches Clinical Trial Following Compelling Early Pancreatic Cancer Data with MRIdian System (PRNewsWire)
    UF startup ViewRay, Inc. announced the launch of a multi-center prospective clinical trial for locally advanced unresectable pancreatic cancer using MRIdian, the world’s first and only FDA-cleared MRI-guided radiation therapy system. This study is the first initiative of ViewRay’s Clinical Cooperative Think Tank (C2T2), a group of MRIdian clinical users focused on evidence gathering to support MR-guided radiation therapy. One particular impetus for the trial was compelling early results presented as part of the scientific sessions at the American Society for Radiation Oncology (ASTRO) annual meeting. The poster, titled “Higher Maximum Biologic Effective Dose Utilizing Adaptive MRI Guided Radiation Therapy Improves Survival of Inoperable Pancreatic Cancer Patients”, provided a retrospective review of 42 locally-advanced pancreatic cancer patients treated at four institutions (Washington University, UCLA, University of Wisconsin, and VUmc). The study found that stereotactic dosing regimens guided by MR imaging and daily online adaptation had led to significantly prolonged patient survival and resulted in favorably low toxicity. ... Read more »

Read More in Our Archive…


 

OTL News and Events

  • UF Incubator News: Innovation Hub Expansion Nears Completion (TV20)
    Since opening its doors in January 2012, the Innovation Hub at UF has provided space and resources for almost 3 dozen local technology startups, creating over 800 new jobs. Now the site is expanding. “We were basically at capacity and yet there were a lot more companies in the community … that needed to have access to the resources and the... Read more »
  • UF Incubator News: Captozyme Named as Florida Company to Watch
    Two University of Florida incubators and GrowFL are pleased to announce that startup Captozyme is among the 50 statewide winners selected for the 2017 Florida Companies to WatchSM. Captozyme, a biotechnology company developing therapeutic enzymes to prevent oxalate kidney stones, has developed its business in both the Innovation Hub at UF and the UF Sid Martin Biotechnology Institute in Alachua.... Read more »
  • UF to Receive Additional $7.4 Million in State Performance Funding (UF News)
    The University of Florida will receive an additional $7.4 million in state performance funding this year versus last year, bringing the total allotted to the university since 2014 to more than $103 million. The money will be used in UF’s ongoing efforts to hire and retain the world’s best and brightest faculty and keep the university on the path to... Read more »
  • New Report: Licensing of Academic Patents Has Contributed up to $1.3 Trillion to US Economy (BusinessWire)
    The licensing of university research has made a significant contribution to US gross domestic product (GDP), industry gross output, and jobs over the last two decades, according to an independent study commissioned by the Biotechnology Innovation Organization (BIO) and the Association of University Technology Managers (AUTM), which was released today. The report, “The Economic Contribution of University/Nonprofit Inventions in the United... Read more »
  • OTL Is Hiring a Licensing Associate
    Do you want to change the world? OTL needs a licensing associate to join with us in our mission, moving inventions from the labs into the marketplace where they can make the world a better place. This licensing associate position assists a licensing team by providing administrative support for all aspects of managing the protection and licensing of new technologies. It involves... Read more »

Read More in Our Archive…


 

Keep up with OTL

Read the latest news about UF startups, OTL, startup companies, programs and events below. If you’d like to have this news delivered via social media or email: